Retatrutide, a novel dual activator of the GLP-1 receptor and glucose-dependent insulinotropic polypeptide (GIP) target, is demonstrating promising results in early human assessments . Ongoing https://shopretatrutidepeptide.com/retatrutide-research-knowledge-hub/